Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. OPKO Health, Inc.
  6. News
  7. Summary
    OPK   US68375N1037

OPKO HEALTH, INC.

(OPK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Dragged Lower in Broad-Based Equities Selloff

01/24/2022 | 01:33pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
MEDIWOUND LTD. -3.97% 1.815 Delayed Quote.-19.92%
NASDAQ COMP. 2.36% 11933.77 Real-time Quote.-25.45%
OPKO HEALTH, INC. 5.39% 3.135 Delayed Quote.-38.25%
PFIZER, INC. 1.34% 51.345 Delayed Quote.-14.19%
TIZIANA LIFE SCIENCES PLC 3.87% 0.89 Delayed Quote.-10.75%
All news about OPKO HEALTH, INC.
05/13OPKO HEALTH, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equit..
AQ
05/10Piper Sandler Adjusts OPKO Health's Price Target to $5 From $6, Reiterates Overweight R..
MT
05/09OPKO HEALTH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
05/09OPKO Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/09Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $329.2M, vs. Street Est of $331.5M
MT
05/09OPKO HEALTH : Q1 Earnings Snapshot
AQ
05/09TRANSCRIPT : OPKO Health, Inc., Q1 2022 Earnings Call, May 09, 2022
CI
05/09OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results
AQ
05/09Opko Health Buys ModeX Therapeutics for $300 Million
MT
05/09OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology wit..
AQ
More news
Analyst Recommendations on OPKO HEALTH, INC.
More recommendations
Financials (USD)
Sales 2022 1 127 M - -
Net income 2022 -168 M - -
Net Debt 2022 - - -
P/E ratio 2022 -12,6x
Yield 2022 -
Capitalization 2 024 M 2 024 M -
Capi. / Sales 2022 1,80x
Capi. / Sales 2023 1,83x
Nbr of Employees 5 767
Free-Float 59,9%
Chart OPKO HEALTH, INC.
Duration : Period :
OPKO Health, Inc. Technical Analysis Chart | OPK | US68375N1037 | MarketScreener
Technical analysis trends OPKO HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 2,97 $
Average target price 6,50 $
Spread / Average Target 119%
EPS Revisions
Managers and Directors
Phillip Frost Chairman & Chief Executive Officer
Jon Roger Cohen Director & Senior Vice President
Adam E. Logal CFO, Treasurer, Chief Accounting Officer & SVP
Jane H. Hsaio Vice Chairman & Chief Technical Officer
Steven D. Rubin Director & Executive Vice President-Administration
Sector and Competitors
1st jan.Capi. (M$)
OPKO HEALTH, INC.-38.25%2 024
JOHNSON & JOHNSON4.10%468 600
PFIZER, INC.-14.19%284 304
ABBVIE INC.14.82%274 733
ELI LILLY AND COMPANY8.38%269 490
ROCHE HOLDING AG-14.96%260 807